GANAXOLONE DERIVATIVES FOR TREATMENT OF CENTRAL NERVOUS SYSTEMS DISORDERS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20170022245A1
SERIAL NO

15039652

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to Ganaxolone prodrugs with increased aqueous solubility and oral bioavailability relative to Ganaxolone and that enable development of stable extended release formulations which offer a significant therapeutic advantage and improved patience compliance by enabling treatments with lower doses over prolonged periods of time.

First Claim

See full text

Other Claims data not available

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOPHARMA WORKS1084 SHENNECOSSETT ROAD GROTON CT 06340

International Classification(s)

loading....
  • 2014 Application Filing Year
  • C07J Class
  • 115 Applications Filed
  • 86 Patents Issued To-Date
  • 74.79 % Issued To-Date
Click to zoom InYear of Issuance% of Matters IssuedCumulative IssuancesYearly Issuances20142015201620172018201920202021202220230255075100

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Marfat, Anthony Mystic, US 79 789
Volkmann, Robert A Mystic, US 78 357

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 0 Citation Count
  • C07J Class
  • 0 % this patent is cited more than
  • 8 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges69452101 - 1011 - 2021 - 30051015202530354045505560657075

Forward Cite Landscape

Load Citation